Inventor
BIFFI ANDREA
IT17 patents
⚠️ This page may combine multiple inventors who share the name “BIFFI ANDREA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALFASIGMA SPA
6 patentsUS12447183B2Oct 21, 2025
Bacterial strains, their compositions and their use for the treatment of gastrointestinal disorders
ALFASIGMA SPA0 citations59
US11752179B2Sep 12, 2023
Medical use of probiotics
ALFASIGMA SPA0 citations58
US11839634B2Dec 12, 2023
Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid
ALFASIGMA SPA0 citations57
US12472214B2Nov 18, 2025
Bacterial strains, the compositions thereof and use thereof in a method for the treatment of vitamin D deficiency, and disorders associated therewith
ALFASIGMA SPA0 citations48
US11751597B2Sep 12, 2023
Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
ALFASIGMA SPA0 citations48
US11896631B2Feb 13, 2024
Probiotics for use in the treatment of diverticulosis and diverticular disease
ALFASIGMA SPA0 citations47
SOFAR SPA
5 patentsUS11464814B2Oct 11, 2022
Topical composition for use in the treatment of inflammatory bowel disease
SOFAR SPA5 citations71
US11400124B2Aug 2, 2022
Use of probiotics for improving protein absorption
SOFAR SPA5 citations71
US11591416B2Feb 28, 2023
Exopolysaccharides and uses thereof
SOFAR SPA3 citations65
US11690889B2Jul 4, 2023
Composition for use in the treatment of intestinal alterations
SOFAR SPA0 citations55
US10881703B2Jan 5, 2021
Composition for use in the treatment of intestinal alterations
SOFAR SPA0 citations55
SOFAR SWISS SA
3 patentsUS12589071B2Mar 31, 2026
Suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and salts thereof
SOFAR SWISS SA0 citations57
US11690867B2Jul 4, 2023
Liquid composition for use in the treatment of gastroesophageal reflux
SOFAR SWISS SA0 citations50
US11337992B2May 24, 2022
Liquid composition for use in the treatment of gastroesophageal reflux
SOFAR SWISS SA0 citations50
LAC2BIOME S R L
3 patentsUS12036254B2Jul 16, 2024
Bacterial strains of the Lactobacillus paracasei species for use, oral or topical, in the treatment of disorders of the female urogenital tract
LAC2BIOME S R L0 citations57
US11534468B2Dec 27, 2022
Composition based on probiotics and uses thereof
LAC2BIOME S R L0 citations57
US11338002B2May 24, 2022
Use for treatment of clostridium difficile infections
LAC2BIOME S R L0 citations57